{"slug":"retatrutide-glp1-gut","verification":{"valid":true,"entries":2,"head":"9f788d55de33c1335d575705f0be1b54c809b29e064ce79f28f3f29f3f29ce8b"},"energy":{"passes":2,"tokens_in":12431,"tokens_out":3414,"tokens_total":15845,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"9f788d55de33c1335d575705f0be1b54c809b29e064ce79f28f3f29f3f29ce8b"},"provenance":[{"ts":"2026-06-30T00:59:09.484Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Retatrutide for Glp1 Gut\nSlug: retatrutide-glp1-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"GLP-1 gut damage / gastroparesis\",\"condition_key\":\"glp1-gut-damage\",\"primary_peptide\":\"retatrutide\",\"peptides_in_scope\":[{\"id\":\"retatrutide\",\"name\":\"Retatrutide\"}],\"drugs_in_scope\":[\"glp1-agonists\"],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have GLP-1 gut damage / gastroparesis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"retatrutide\",\"name\":\"Retatrutide\",\"section_title\":\"Why Retatrutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\",\"**What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\",\"**What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\",\"**Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\\n3. ","response":"{\n  \"slug\": \"retatrutide-glp1-gut\",\n  \"title\": \"Retatrutide for GLP-1 Gut Damage: Weight Loss Pathways vs Gastric Slowing Evidence\",\n  \"body\": \"## What's breaking down if you have GLP-1 gut damage / gastroparesis\\n\\nIf GLP-1 agonists have slowed your gastric emptying, the core issue is delayed stomach emptying. Food stays longer in the stomach. This leads to nausea, bloating, early fullness, and sometimes vomiting. The mechanism is the GLP-1 pathway itself, which slows motility to reduce calorie intake. No tissue breakdown like disc degeneration occurs here. Instead, the drug action directly affects gut motility. Rapid weight loss from these drugs can also reduce muscle mass, which may compound metabolic issues over time. The condition persists if the slowing effect continues without dose adjustment or cessation.\\n\\n## Why Retatrutide might help you\\n\\n1. You are reading about **GLP-1 gut damage / gastroparesis** — what breaks down matters before any compound name.\\n2. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\\n3. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\\n4. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\\n\\nRetatrutide activates GLP-1, GIP, and glucagon receptors. This triple action drives greater weight reduction than single or dual agonists in phase 2 data. If excess weight adds mechanical stress elsewhere in your body, the resulting loss could ease that load. However, retatrutide also delays gastric emptying via its GLP-1 component. This is the same pathway linked to gastroparesis symptoms in the class. For someone already experiencing GLP-1 gut damage, the weight loss benefit sits alongside the risk of further or prolonged motility slowing. No direct repair of damaged","tokens_in":12431,"tokens_out":3414,"cost":0,"prev":"genesis","hash":"dd6bfc4da6dbd06758fa93d19e21aa8dcf131e3b7fa2df337367d4888798f5ff"},{"ts":"2026-07-17T02:41:17.200Z","model":"owner","action":"voxel_divide","prompt":"","input":"retatrutide-glp1-gut","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"dd6bfc4da6dbd06758fa93d19e21aa8dcf131e3b7fa2df337367d4888798f5ff","hash":"9f788d55de33c1335d575705f0be1b54c809b29e064ce79f28f3f29f3f29ce8b"}]}